Julia DeCesare
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
This article is a stub. |
Julia C DeCesare was trial manager of the PACE trial until 2008, and is now an Associate Director for Study Management at pharmaceutical company AstraZeneca.[1]
Notable studies[edit | edit source]
PACE trial publications include:
- Main trial outcome
- 2011, Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial[2]
- Other PACE trial publications
- 2013, A randomised trial of adaptive pacing therapy, cognitive behaviour therapy, graded exercise, and specialist medical care for chronic fatigue syndrome (PACE): statistical analysis plan[3]
Letters[edit | edit source]
- 2017, Response to the editorial by Dr Geraghty[4] (Full text)
Talks and interviews[edit | edit source]
Online presence[edit | edit source]
- PubMed
- Website
- YouTube
See also[edit | edit source]
Learn more[edit | edit source]
References[edit | edit source]
- ↑ "Julia DeCesare". LinkedIn. Retrieved February 26, 2019.
- ↑ White, PD; Goldsmith, KA; Johnson, AL; Potts, L; Walwyn, R; DeCesare, JC; Baber, HL; Burgess, M; Clark, LV; Cox, DL; Bavinton, J; Angus, BJ; Murphy, G; Murphy, M; O'Dowd, H; Wilks, D; McCrone, P; Chalder, T; Sharpe, M; The PACE Trial Management Group (March 5, 2011), "Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial", The Lancet, 377 (9768): 823–836, doi:10.1016/S0140-6736(11)60096-2, PMID 21334061
- ↑ Walwyn, R; Potts, L; McCrone, P; Johnson, AL; DeCesare, JC; Baber, HL; Goldsmith, KA; Sharpe, M; Chalder, T; White, PD (November 13, 2013). "A randomised trial of adaptive pacing therapy, cognitive behaviour therapy, graded exercise, and specialist medical care for chronic fatigue syndrome (PACE): statistical analysis plan". Trials Journal. 14: 386. doi:10.1186/1745-6215-14-386. PMC 4226009. PMID 24225069.
- ↑ White, PD; Chalder, T; Sharpe, M; Angus, BJ; Baber, HL; Bavinton, J; Burgess, M; Clark, LV; Cox, DL; DeCesare, JC; Goldsmith, KA; Johnson, AL; McCrone, P; Murphy, G; Murphy, M; O'Dowd, H; Potts, L; Walwyn, R; Wilks, D (January 2017). "Response to the editorial by Dr Geraghty". Journal of Health Psychology. 22 (9): 1113–1117. doi:10.1177/1359105316688953.